| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.06 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |